Abstract
Intranasal administration of a galanin receptor blocker to rats was found to change their behavioral type on being placed in an unfamiliar environment, with decreases in movement and investigative activity and increases in the level of anxiety in the open field test. The basal level of expression of the galanin precursor mRNA in the anterior hypothalamus was significantly higher in rats with the active type of behavior in the open field test. In conditions of galanin receptor blockade, there was also a faster increase in the serum corticosterone level in response to a stress situation (forced swimming test), which was accompanied by a reduction in the immobilization time. These data support the involvement of galanin in the formation of individual-typological behavioral characteristics and demonstrate its important role in adaptation to stress.
Similar content being viewed by others
References
E. V. Koplik, R. M. Salieva, and A. V. Gorbunova, “The open field test as a predictor of criteria for resistance to emotional stress in Wistar rats,” Zh. Vyssh. Nerv. Deyat., 45, No. 4, 775–781 (1995).
M. G. Pshennikova, “The phenomenon of stress. Emotional stress and its role in pathology,” Pat. Fiziol. Éksperim. Ter., 2, 24–31 (2000).
E. V. Sidorenko, Methods of Mathematical Analysis in Psychology [in Russian], Rech’, St. Petersburg (2004).
K. V. Sudakov, “The individuality of emotional stress,” Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 105, No. 2, 4–12 (2005).
E. A. Yumatov, “Neurotransmitter integration of emotional excitation and the mechanisms of resistance to stress,” Vest. Ros. Akad. Med. Nauk., 11, 9–16 (1995).
T. Bartfai, K. Bedecs, T. Land, U. Langel, R. Bertorelli, P. Girotti, S. Consolo, X. Xu, Z. Wiesenfeld-Hallin, S. Nilsson, V. A. Pieribone, and T. Hokfelt, “M-15: high affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus and spinal cord,” Proc. Natl. Acad. Sci. USA, 88, 10961 (1991).
T. Bartfai, T. Hokfelt, and U. Langel, “Galanin — a neuroendocrine peptide,” Crit. Rev. Neurobiol., 7, No. 3/4, 229–274 (1993).
S. A. Chepurnov, N. E. Chepurnova, and R. K. Berdiev, “Galanin controls excitability of the brain,” Ann. N.Y. Acad. Sci., 865, 547–0550 (1998).
T. Hokfelt, Z. Xu, T. Shi, K. Holmberg, and X. Zhang, “Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline,” Ann. N.Y. Acad. Sci., 863, 252–263 (1998).
P. V. Holmes, D. C. Blanchard, R. J. Blanchard, L. S. Brady, and J. N. Crawley, “Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus,” Pharmacol. Biochem. Behav., 50, No. 4, 655–660 (1995).
A. Holmes, J. M. Kinney, C. C. Wrenn, Q. Li, R. J. Yang, L. Ma, J. Vishwanath, M. C. Saavedra, C. E. Innerfield, A. S. Jacoby, J. Shine, T. P. Iismaa, and J. N. Crawley, “GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze,” Neuropsychopharmacol., 28, No. 6, 1031–1044 (2003).
A. Holmes, R. J. Yang, and J. N. Crawley, “Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice,” J. Mol. Neurosci., 18, No. 1–2, 151–165 (2002).
S. C. Hooi, D. M. Maiter, J. B. Martin, and J. I. Koenig, “Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat,” Endocrinol., 127, 2281–2289 (1990).
K. Kask, U. Langel, and T. Bartfai, “Galanin — a neuropeptide with inhibitory actions,” Cell. Mol. Neurobiol., 15, No. 6, 653–672 (1995).
K. Kask, M. Berthold, and T. Bartfai, “Galanin receptors: involvement in feeding, pain, depression and Alzheimer’s disease,” Life Sci., 60, No. 18, 1523–1533 (1997).
H. Khoshbouei, M. Cecchi, S. Dove, M. Javors, and D. A. Morilak, “Behavioral reactivity to stress. Amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala,” Pharmacol. Biochem. Behav., 71, No. 3, 407–417 (2002).
G. A. Kinney, P. J. Emmerson, and R. J. Miller, “Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus,” J. Neurosci., 18, No. 10, 3489–3500 (1998).
J. M. Koolhaas, S. M. Korte, S. F. De Boer, B. J. Van Der Vegt, C. G. Van Reenen, H. Hopster, I. C. De Long, M. A. Ruis, and H. J. Blokhuis, “Coping styles in animals, current status in behavior and stress physiology,” Neurosci. Biobehav. Rev., 23, 925–935 (1999).
V. Lioudyno, S. Tsikunov, and V. Klimenko, “The role of amygdala galanin in coping with psychological stress,” Acta Neurobiol. Exp., 65, 359 (2005).
L. Lundstrom, A. Elmquist, T. Bartfai, and U. Langel, “Galanin and its receptors in neurological disorders,” Neuromol. Med., 7, No. 1–2, 157–180 (2005).
A. M. Mazarati, “Galanin and galanin receptors in epilepsy,” Neuropeptides, 38, No. 6, 331–343 (2004).
M. Niimi, J. Takahara, and K. Kawanishi, “Corticotropin releasing factor and galanin-containing neurons projecting to the median eminence of the rat,” Neurosci. Res., 14, 295–299 (1992).
H. A. O’Neal, V. J. D. Hoomissen, P. V. Holmes, and R. K. Dishman, “Preprogalanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training,” Neurosci. Lett., 299, No. 1–2, 69–72 (2001).
M. Palkovits, “Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons,” Eur. J. Pharmacol., 405, No. 1–3, 161–166 (2000).
M. C. Pardon, G. G. Gould, A. Garcia, L. Phillips, M. C. Cook, S. A. Miller, P. A. Mason, and D. A. Morilak, “Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders,” Neurosci., 115, No. 1, 229–242 (2002).
G. Skofitsch and D. M. Jacobowitz, “Immunohistochemical mapping of galanin-like neurons in the rat central nervous system,” Peptides, 6, 509–546 (1985).
A. H. Veenema, O. C. Meijer, E. R. De Kloet, J. M. Koolhaas, and B. G. Bohus, “Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression,” Hormones Behav., 43, 197–204 (2003).
S. Zini, M. P. Rosen, U. Langel, T. Bartfai, and Y. Ben-Ari, “Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus,” Eur. J. Pharmacol., 245, No. 1, 1–7 (1993).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 92, No. 10, pp. 1204–1211, October, 2006.
Rights and permissions
About this article
Cite this article
Lyudyno, V.I., Abdurasulova, I.N. & Klimenko, V.M. The role of the neuropeptide galanin in forming type-specific behavioral characteristics. Neurosci Behav Physi 38, 93–98 (2008). https://doi.org/10.1007/s11055-008-0013-3
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11055-008-0013-3